Skip to main content
ISTH 2023 Main banner
Back

    Arjan W. Griffioen, PhD (he/him/his)

    Professor, Head of the Angiogenesis Laboratory
    Amsterdam UMC
    Amsterdam, Netherlands

    Prof. dr. Arjan W. Griffioen studied medical biology at the Free University in Amsterdam and got his PhD in 1991 from the Utrecht University for his thesis on human B lymphocyte activation. In this year he also received his SMBWO-registration as immunologist. He performed his first postdoctoral research at the Academic Medical Center and at University Medical Center Utrecht. In 1997 he was appointed at the Department of Internal Medicine of the University Hospital Maastricht. After a sabbatical leave to the University of Minnesota in Minneapolis in 2001, he was appointed at the Department of Pathology as Full Professor in Experimental Oncology and Angiogenesis.
    The Angiogenesis Laboratory is currently located at the Amsterdam UMC and hosts now about 20 researchers working on the mechanisms of angiogenesis and the development of novel treatment strategies for cancer. The major research lines are centered around gene expression profiling of tumor endothelial cells and making vaccines against cancer targeted towards tumor endothelial cell markers.
    Dr. Griffioen has authored 281 peer-reviewed scientific publications (H-index 85) and joins the editorial board of several international scientific journals. He founded the Springer-Nature journal Angiogenesis (IF 10.658) in 1997 and is since then serving the journal as Editor-in-Chief. He is founder and Chief Scientific Officer of the biotech company CimCure BV. Also, he is director of the Graduate School Oncology Amsterdam (OOA) and from 2010-2022 he was director of the Master Oncology program at the VU University.

    Presentation(s):